Will Roche mess up a good thing? - Recensione dipendente - Dipendente anonimo presso Genentech

4,0
29 dic 2009
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Focus on patients, great science, and innovation. Lots of talented employees. Unique culture of casual intensity. In terms of drug R&D, probably as good as it's reputation.

Svantaggi

Senior management seem unaware of how competitive it is below them. Promotion opportunities are limited. Everyone takes a title cut to work at GNE. Even though there is lip service to pushing decision making down to lowest possible level, sr. management tends to micromanage everything. Very uncertain atmosphere since Roche takeover. Lots of great people have left in the last 8 months, including virtually all major players from the former GNE Exec. Comm.

Esplora altre recensioni su Genentech

5,0
6 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great salary and team! The interview process was smooth and effective.

Svantaggi

To be determined, but so far many alignment meetings. Some folks have frustuations around the re-org and strategy changes.

2,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The work is meaningful and overall the company vision aligns with my goals

Svantaggi

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Vedi recensioni per: Utile|Valutazione|Data|Tutto